EXPERIMENTAL EVIDENCES FOR THE PROMISING HERAPEUTIC ROLE OF VITIS VINIFERA SEED EXTRACT AGAINST NONALCOHOLIC STEATOHEPATITIS

  • Hanaa H. Ahmed National Research Centre
  • Ahmed M. Salem Ain Shams University
  • Mohamed R. Mohamed Ain Shams University
  • Abdelaaty A Shahat National Research Centre
  • Wagdy Kb Khalil National Research Centre
  • Safaa H. Mohamed National Research Centre

Abstract

Objective: The present study was planned to investigate the possible therapeutic effect of methanolic extract of Vitis vinifera seeds on high fat diet-induced nonalcoholic steatohepatitis (NASH) in forty adult female Wistar rats.

Methods: The animals were divided into four groups, (G1)was served as healthy control group and the other three groups received high fat diet for 32 weeks for induction of NASH were assigned as follow: (G2) in which the animals bearing NASH were left untreated, (G3) in which the animals bearing NASH were treated with Vitis vinifera seed extract in a dose of 0.28g/kg b. wt (GSH) and (G4) in which the animals bearing NASH were treated with Vitis vinifera seed extract in a dose of 0.14g/kg b. wt (GSL).

Results: The results revealed significant increase in serum ALT activity, plasma glucose, insulin levels, serum resist in, NF-κB, TNF-α, HGF levels, hepatic TNF-α and HGF gene expression levels. While, serum albumin, adiponectin levels and hepatic adiponectin gene expression level were decreased significantly in NASH group. Conversely, treatment of NASH groups with GSH or GSL resulted in significant decrease in serum ALT activity, plasma glucose, insulin levels, serum resist in, NF-κB, TNF-α, HGF levels, hepatic TNF-α and HGF gene expression levels. However, serum albumin, adiponectin levels and hepatic adiponectin gene expression level were increased significantly as a consequence of treatment with GSH or GSL.

Conclusions: The efficacy of Vitis vinifera extract against NASH might be attributed to its strong hepatoprotective potential and powerful anti-inflammatory activity in addition to its potent role in ameliorating insulin resistance indices.

 

Keywords: Nonalcoholic steatohepatitis, Vitis vinifera, Inflammation, Insulin resistine, Rats

Downloads

Download data is not yet available.

References

1. Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezyńska-Kurtycz J, Milkiewicz P. Non-alcoholic fatty liver disease--new view. Pol Merkur Lekarski 2008;24:568-71.
2. Tran A, Gual P. Non-alcoholic steatohepatitis in morbidly obese patients. Clin Res Hepatol Gastroenterol 2013;37:17-29.
3. Khoshbaten M, Aliasgarzadeh A, Masnadi K, Tarzamani MK, Farhang S, Babaei H, et al. N-acetylcysteine improves liver function in patients with non-alcoholic Fatty liver disease. Hepat Mon 2010;10:12-6.
4. Preiss D, Sattar N. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin Sci 2008;115:141–50.
5. Shin M, Moon J. Effect of dietary supplementation of grape skin and seeds on liver fibrosis induced by dimethylnitrosamine in rats. Nutr Res Pract 2010;4:369-74.
6. Kris-Etherton PM, Lefevre M, Beecher GR, Gross MD, Keen CL, Etherton TD. Bioactive compounds in nutrition and health-research methodologies for establishing biological function: the antioxidant and anti-inflammatory effects of flavonoids on atherosclerosis. Annu Rev Nutr 2004;24:11–38.
7. Tipoe GL, Ho CT, Liong EC, Leung TM, Lau TYH, Fung ML, Nanji AA. Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD). Histol Histopathol 2009;24:1161-9.
8. Reeves PG, Nielsen FH, Fahey GC. AIN-93 purified diets for laboratory rodents: final report of the american institution ad hoc. writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993;123:1939-51.
9. Sandford HS. Method for obtaining venous blood from the orbital sinus of the rat or mouse. Sci 1954;119:100.
10. Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Path 1957;28:56-63.
11. Dumas BT, Biggs HG. In Standard Methods of Clinical Chemistry. Vol. 7. Acadamic Press: New York; 1972. p. 175.
12. Howanitz PJ, Howantiz JH. In Clinical Diagnosis and Management by Laboratory Methods, 17th ed. JB Henry, Ed. WB Saunders Philadelphia; 1984. p. 168.
13. Temple R, Clark PMS, Hales CN. Measurement of insulin secretion in type 2 diabetes: problems and pitfalls. Diabetic Med 1992;9:503-12.
14. Duncan MH, Singh BM, Wise PH, Carter G, Alaghband ZJ. A simple measure of insulin resistance. Lancet 1995;346:120-1.
15. Pannacciulli N, Vettor R, Milan G, Granzotto M, Catucci A, Federspil G, et al. Anorexia nervosa is characterized by increased adiponectin plasma levels and reduced nonoxidative glucose metabolism. J Clin Endocrinol Metab 2003;88:1748-52.
16. Schäffler A, Büchler C, Müller-Ladner U, Herfarth H, Ehling A, Paul G, et al. Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus. Horm Metab Res 2004;36:702-7.
17. Brouckaert P, Libert C, Everaerdt B, Takahashi N, Cauwels A, Fiers W. Tumor necrosis factor, its receptors and the connection with interleukin-1 and interleukin-6. Immunobiol 1993;187:317-29.
18. Plum L, Lin HV, Dutia R, Tanaka J, Aizawa KS. The obesity susceptibility gene carboxypeptidase e links foxO1 signaling in hypothalamic pro–opiomelanocortin neurons with regulation of food intake. Nat Med 2009;15(10):1195-201.
19. Ali FKh, El-Shafai SA, Samhan FA, Khalil WKB. Effect of water pollution on expression of immune response genes of Solea aegyptiaca in Lake Qarun. Afr J Biotechnol 2008;7:1418-25.
20. Kaser S, Moschen A, Cayon A, Kaser A, Crespo J, Pons-Romero F, et al. Adiponectin and its receptors in non-alcoholic steatohepatitis. Gut 2005;54:117–21.
21. Liu J, Lei D, Waalkes MP, Beliles RP, Morgan DL. Genomic analysis of the rat lung following elemental mercury vapor exposure. Toxicol Sci 2003;74:174–81.
22. Hata J, Ikeda E, Uno H, Asano S. Expression of hepatocyte growth factor mRNA in rat liver cirrhosis induced by N-nitrosodimethylamine as evidenced by in situ RT-PCR. J Histochem Cytochem 2002;50:1461–8.
23. Gaytan F, Barreiro ML, Caminos JE, Chopin LK, Herington AC, Morales C, et al. Expression of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in normal human testis and testicular tumors. J Clin Endocrinol Metab 2004;89:400-9.
24. Bio-Rad Laboratories Inc: Real-Time PCR applications guide. Bull 2006;5279:101.
25. Armitage P, Berry G. Comparison of several groups. In: statistical method in medical research 2nd Ed. Blockwell significant publication. Oxford; 1987. p. 186-213.
26. Hooper AJ, Adams LA, Burnett JR. Genetic determinants of hepatic steatosis in man. J Lipid Res 2011;52:593-617.
27. Yang RZ, Park S, Reagan WJ, Goldstein R, Zhong S, Lawton M, et al. Alanine aminotransferase isoenzymes: molecular cloning and quantitative analysis of tissue expression in rats and serum elevation in liver toxicity. Hepatol 2009;49(2):598–607.
28. Videla L. Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms. World J Hepatol 2009;1:72-8.
29. Jacobs M, Van Greevenbroek MMJ, Van der Kallen CJH, Ferreira I, Feskens EJM, Jansen EHJM, et al. The association between the metabolic syndrome and alanine amino transferase is mediated by insulin resistance via related metabolic intermediates (the Cohort on Diabetes and Atherosclerosis Maastricht [CODAM] study). Metab 2011;60:969–75.
30. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis: liver failure and liver disease. Hepatol 2006;43:99-112.
31. Amirtharaj GJ, Natarajan SK, Mukhopadhya A, Zachariah UG, Hegde SK, Kurian G, et al. Fatty acids influence binding of cobalt to serum albumin in patients with fatty liver. Biochim Biophys Acta 2008;1782:349–54.
32. Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002;23:201–29.
33. Yilmaz Y, Toledo RT. Major flavonoids in grape seeds and skins: antioxidant capacity of catechin, epicatechin, and gallic acid. J Agric Food Chem 2004;52:255–60.
34. Simonetti P, Ciappellano S, Gardana C, Bramati L, Pietta P. Procyanidins from Vitis vinifera seeds: in vivo effects on oxidative stress. J Agric Food Chem 2002;50:6217–21.
35. Terra X, Pallarés V, Ardèvol A, Bladé C, Fernández-Larrea J, Pujadas G, et al. Modulatory effect of grape-seed procyanidins on local and systemic inflammation in diet-induced obesity rats. J Nutr Biochem 2011;22:380-7.
36. Suwannaphet W, Meeprom A, Yibchok-Anun S, Adisakwattana S. Preventive effect of grape seed extract against high-fructose diet-induced insulin resistance and oxidative stress in rats. Food Chem Toxicol 2010;48:1853–7.
37. El-Shafeey M, El-Adawi H, Al-Azhari D, Abd El-Wahab A, Abdel-Mohsen. Synergistic effect of milk thistle and grape seed extracts on the recovery of fumonisin b1 toxicity in rats. Egypt Acad J Biol Sci 2012;4:63-85.
38. Yun JW, Cho YK, Park JH, Kim HJ, Park D, Sohn C, et al. Abnormal glucose tolerance in young male patientswith nonalcoholic fatty liver disease. Liver Int 2009;29:1478-3223.
39. Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. Can Med Assoc J 2005;172:367-79.
40. Ginsberg HN, Stalenhoef AF. The metabolic syndrome targeting dyslipidemia to reduce coronary risk. J Cardiovasc Risk 2003;10:121-8.
41. Adams LA, Angulo P. Recent concepts in non-alcoholic fatty liver disease. Diabetic Med 2005;22:1129-33.
42. Bril F, Lomonaco R, Orsak B, Ortiz-Lopez C, Webb A, Tio F, et al. Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis. Hepatology 2014;59:2178-87.
43. Jung HL, Kang HY. Effects of endurance exercise and high-fat diet on insulin resistance and ceramide contents of skeletal muscle in sprague-dawley rats. Korean Diabetes J 2010;34:244–52.
44. Wilcox G. Insulin and insulin resistance. Clin Biochem Rev 2005;26:19–39.
45. Rostamian V, Shakeri F, Estakhr J. The effect of hydro-alcoholic extract of grape seed (Vitis vinifera) on sugar and lipids in serum of diabetic rats. Res J Biol Sci 2011;6:547-9.
46. Cedó L, Castell-Auví A, Pallarès V, Blay M, Ardévol A, Pinent M. Grape seed procyanidin extract improves insulin production but enhances bax protein expression in cafeteria-treated male rats. Int J Food Sci 2013;2013:7.
47. Cho SY, Park PJ, Shin HJ, Kim YK, Shin DW, Shin ES, et al. (-)-Catechin suppresses expression of Kruppel-like factor 7 and increases expression and secretion of adiponectin protein in 3T3-L1 cells. Am J Physiol Endocrinol Metab 2007;292:E1166-72.
48. Castell-Auví A, Cedó L, Pallarès V, Blay M, Pinent M, Ardévol A. Grape seed procyanidins improve β-cell functionality under lipotoxic conditions due to their lipid-lowering effect. J Nutr Biochem 2013;24:948–53.
49. Terra X, Ardèvol A, Bladé C, Fernández-Larrea J, Pujadas G, Salvadó J, et al. Inhibitory effects of grape seed procyanidins on foam cell formation in vitro. J Agric Food Chem 2009;57:2588-94.
50. Pagano C, Soardo G, Esposito W. Plasma adiponectin is decreased in nonalcoholic fatty liver disease. Eur J Endocrinol 2005;152:113–8.
51. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114:1752–61.
52. Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2002;96:1723–32.
53. Crespo J, Cayón A, Fernández-Gil P, Hernández-Guerra M, Mayorga M, Domínguez-Díez A, et al. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 2001;34:1158–63.
54. Pagano C, Soardo G, Pilon C, Milocco C, Basan L, Milan G, et al. Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. J Clin Endocrinol Metab 2006;91:1081–6.
55. Bajaj M, Suraamornkul S, Hardies LJ, Pratipanawatr T, DeFronzo RA. Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients. Int J Obes Relat Metab Disord 2004;28:783–9.
56. Murad A, Hassan H, Husein H, Ayad A. Serum resistin levels in nonalcoholic fatty liver disease and their relationship to severity of liver disease. J Endocrinol Metab Diabetes South Africa 2010;15:53-6.
57. Décordé K, Teissèdre PL, Sutra T, Ventura E, Cristol JP, Rouanet JM. Grape-seed procyanidins prevent low-grade inflammation by modulating cytokine expression in rats fed a high-fat diet. Mol Nutr Food Res 2009;53:659–66.
58. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006;116:1784–92.
59. Barona J, Blesso CN, Andersen CJ, Park Y, Lee J, Fernandez ML. Grape consumption increases anti-inflammatory markers and upregulates peripheral nitric oxide synthase in the absence of dyslipidemias in men with metabolic syndrome. Nutr 2012;4:1945–57.
60. Georgiev V, Ananga A, Tsolova V. Recent advances and uses of grape flavonoids as nutraceuticals. Nutr 2014;6:391–415.
61. Gonzalez-Castejon M, Rodriguez-Casado A. Dietary phytochemicals and their potential effects on obesity: a review. Pharmacol Res 2011;64:438–55.
62. Meeprom A, Sompong W, Suwannaphet W, Yibchok-anun S, Adisakwattana S. Grape seed extract supplementation prevents high-fructose diet-induced insulin resistance in rats by improving insulin and adiponectin signaling pathways. Br J Nutr 2011;106:1173–81.
63. Graf D, Seifert S, Jaudszus A, Bub A, Watzl B. Anthocyanin-Rich juice lowers serum cholesterol, Leptin, and Resistin and Improves plasma fatty acid composition in fischer rats. PLoS ONE 2013;8(6):e66690.
64. Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, Cummins AG. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumor necrosis factor a in the pathogenesis of non-alcoholic steatohepatitis. Gut 2001;48:206–11.
65. Lieber CS, Leo MA, Mak KM, Xu Y, Cao Q, Ren C, et al. Model of nonalcoholic steatohepatitis. Am Soc Clin Nutr 2004;79:502–9.
66. Fain JN, Bahouth SW, Madan AK. TNF [alpha] release by the nonfat cells of human adipose tissue. Int J Obes Relat Metab Disord 2004;28:616–22.
67. Ruiz AG, Casafont F, Crespo J, Cayón A, Mayorga M, Estebanez A, et al. Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis. Obes Surg 2007;17:1374-80.
68. Baumgardner JN, Shankar K, Hennings L, Badger TM, Ronis MJJ. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet. Am J Physiol Gastrointest Liver Physiol 2008;294:G27–G38.
69. Baeuerle PA, Henkel T. Function and activation of NF-kB in the immune system. Ann Rev Immunol 1994;12:141–79.
70. Tian N, Moore RS, Braddy S, Rose RA, Gu JW, Hughson MD, et al. Interactions between oxidative stress and inflammation in salt-sensitive hypertension. Am J Physiol Heart Circ Physiol 2007;293:H3388–H3395.
71. Koutsogiannis D, Summers K, George B, Adams P, Marotta P, Chakrabarti S. Identification of serum biomarkers in end stage liver disease. Open Biomarkers J 2010;3:1-6.
72. Fausto N, Laird AD, Webber EM. Role of growth factors and cytokines in hepatic Regeneration. FASEB J 1995;9:1527-36.
73. Zhong JY, Cong HQ, Zhang LH. Inhibitory effects of grape procyanidins on free radical-induced cell damage in rat hepatocytes in vitro. World J Gastroenterol 2007;13:2752-5.
74. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796–808.
75. Balaban YH, Sumer H, Simsek H, Us D, Tatar G. Metabolic syndrome, non-alcoholic steatohepatitis (NASH), and hepatocyte growth factor (HGF). Ann Hepatology 2006;5:109-14.
Statistics
295 Views | 597 Downloads
How to Cite
Ahmed, H. H., A. M. Salem, M. R. Mohamed, A. A. Shahat, W. K. Khalil, and S. H. Mohamed. “EXPERIMENTAL EVIDENCES FOR THE PROMISING HERAPEUTIC ROLE OF VITIS VINIFERA SEED EXTRACT AGAINST NONALCOHOLIC STEATOHEPATITIS”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 7, no. 2, Dec. 2014, pp. 417-24, https://innovareacademics.in/journals/index.php/ijpps/article/view/4107.
Section
Original Article(s)